Clinical Characteristics of SGLT2 Inhibitor User in Type 2 Diabetes with Atherosclerotic Cardiovascular Disease or Heart Failure in a Real-World Setting

Citation
Jeong SJ, Park IEB, Lee SE, et al. Diabetes 2019;68(Suppl 1):2346-PUB.